{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:28:22Z","timestamp":1783740502018,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.012","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T20:06:41Z","timestamp":1650744401000},"page":"3236-3243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis"],"prefix":"10.1016","volume":"40","author":[{"given":"Barbara","family":"Streckenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Baldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Heidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Frahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvan Elias","family":"Langhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Mashhadiakbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe Klaus","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2022.04.012_b0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/14656566.2018.1446944","article-title":"Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients","volume":"19","author":"Rommer","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.012_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.vaccine.2022.04.012_b0015","unstructured":"Multiple Sclerosis International Federation. Atlas of MS. Available from: https:\/\/www.atlasofms.org\/map\/germany\/epidemiology\/number-of-people-with-ms, 2020 [accessed 14 January 2022]."},{"issue":"14","key":"10.1016\/j.vaccine.2022.04.012_b0020","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Longo","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.012_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-13-128","article-title":"Incidence and prevalence of multiple sclerosis in Europe: a systematic review","volume":"13","author":"Kingwell","year":"2013","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.autrev.2011.05.008","article-title":"Immune-mediated CNS diseases: a review on nosological classification and clinical features","volume":"11","author":"Zettl","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"07","key":"10.1016\/j.vaccine.2022.04.012_b0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/a-0985-4124","article-title":"Multiple Sklerose in Deutschland: aktualisierte Auswertungen des MS-Registers der DMSG 2014\u20132018","volume":"88","author":"Flachenecker","year":"2020","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"10","key":"10.1016\/j.vaccine.2022.04.012_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101510","article-title":"Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis","volume":"11","author":"Hecker","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0036-1579693","article-title":"Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update","volume":"36","author":"Ascherio","year":"2016","journal-title":"Semin Neurol"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.012_b0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2016.21","article-title":"Disease-modifying therapies and infectious risks in multiple sclerosis","volume":"12","author":"Winkelmann","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.vaccine.2022.04.012_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102822","article-title":"Merits and culprits of immunotherapies for neurological diseases in times of COVID-19","volume":"56","author":"Pawlitzki","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/WCO.0000000000000824","article-title":"Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis","volume":"33","author":"Moiola","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.autrev.2011.05.015","article-title":"Immunization in the adult immunocompromised host","volume":"11","author":"L\u00f6bermann","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2022.04.012_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01883","article-title":"Vaccination in Multiple Sclerosis: Friend or Foe?","volume":"10","author":"Zrzavy","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2016808","article-title":"Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report","volume":"36","author":"Chen","year":"2016","journal-title":"Crit Care Nurse"},{"issue":"12","key":"10.1016\/j.vaccine.2022.04.012_b0085","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","article-title":"Post-vaccination encephalomyelitis: literature review and illustrative case","volume":"15","author":"Huynh","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.53.2.396","article-title":"Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?","volume":"53","author":"Tourbah","year":"1999","journal-title":"Neurology"},{"issue":"8776","key":"10.1016\/j.vaccine.2022.04.012_b0095","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0140-6736(91)92034-Y","article-title":"Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine","volume":"338","author":"Herroelen","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.012_b0100","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2022.04.012_b0105","first-page":"8","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccinations and Autoimmune Diseases Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2022.04.012_b0110","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1212\/WNL.0000000000008012","article-title":"A large case-control study on vaccination as risk factor for multiple sclerosis","volume":"93","author":"Hapfelmeier","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2022.04.012_b0115","unstructured":"St\u00e4ndige Impfkommission. Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2021. Epid Bull 2021; 34:3-63. 10.25646\/8824; Available from: https:\/\/www.rki.de\/DE\/Content\/Infekt\/EpidBull\/Archiv\/2021\/Ausgaben\/34_21.pdf?__blob=publicationFile, 2022 [accessed 14 January 2022]."},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.012_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10654-019-00595-2","article-title":"Hospitalization following influenza infection and pandemic vaccination in multiple sclerosis patients: a nationwide population-based registry study from Norway","volume":"35","author":"Ghaderi","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.012_b0125","first-page":"105","article-title":"Vaccination coverage in immunosuppressed patients: results of a regional health services research study","volume":"108","author":"Teich","year":"2011","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1590\/0004-282X20140234","article-title":"Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale","volume":"73","author":"Lima","year":"2015","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.012_b0135","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1186\/s12889-020-09840-w","article-title":"Personality and individual attitudes toward vaccination: a nationally representative survey in the United States","volume":"20","author":"Lin","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2022.04.012_b0145","unstructured":"World Medical Association. WMA Declaration of Helsinki \u2013 ethical principles for medical research involving human subjects. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/.2018 [accessed 14 January 2022]."},{"issue":"11","key":"10.1016\/j.vaccine.2022.04.012_b0150","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2022.04.012_b0155","series-title":"Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual","author":"Costa","year":"1992"},{"key":"10.1016\/j.vaccine.2022.04.012_b0160","series-title":"NEO-F\u00fcnf-Faktoren-Inventar nach Costa und McCrae","author":"Borkenau","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.012_b0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1073191110368482","article-title":"The NEO-FFI in Multiple Sclerosis: internal consistency, factorial validity, and correspondence between self and informant reports","volume":"18","author":"Schwartz","year":"2011","journal-title":"Assessment"},{"issue":"12","key":"10.1016\/j.vaccine.2022.04.012_b0170","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archpsyc.1993.01820240059008","article-title":"A psychobiological model of temperament and character","volume":"50","author":"Cloninger","year":"1993","journal-title":"Arch Gen Psychiatry"},{"issue":"3 Pt 2","key":"10.1016\/j.vaccine.2022.04.012_b0175","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2466\/pr0.2003.93.3f.995","article-title":"Further development of the Temperament and Character Inventory","volume":"93","author":"Br\u00e4ndstr\u00f6m","year":"2003","journal-title":"Psychol Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1026\/\/0084-5345.29.2.117","article-title":"Die deutschsprachigen Version des Temperament- und Charakterinventars (TCI)","volume":"29","author":"Richter","year":"2000","journal-title":"Z Klin Psychol Psychother"},{"issue":"6","key":"10.1016\/j.vaccine.2022.04.012_b0185","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.vaccine.2022.04.012_b0190","unstructured":"Herrmann-Lingen C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale - Deutsche Version: Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R. P. Snaith und A. S. Zigmond. 4th ed. G\u00f6ttingen: Hogrefe; 2010."},{"key":"10.1016\/j.vaccine.2022.04.012_b0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1192\/bjp.179.6.540","article-title":"Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population","volume":"179","author":"Mykletun","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"6","key":"10.1016\/j.vaccine.2022.04.012_b0210","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","article-title":"Vaccines and multiple sclerosis: a systematic review","volume":"264","author":"Mailand","year":"2017","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.012_b0215","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00415-011-5984-2","article-title":"Immunizations and risk of multiple sclerosis: systematic review and meta-analysis","volume":"258","author":"Farez","year":"2011","journal-title":"J Neurol"},{"issue":"26","key":"10.1016\/j.vaccine.2022.04.012_b0220","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/j.vaccine.2018.05.063","article-title":"Vaccines and the risk of acute disseminated encephalomyelitis","volume":"36","author":"Chen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.012_b0200","unstructured":"Robert Koch Institut. Immunisation schedule, https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/Materialien\/Downloads-Impfkalender\/Impfkalender_Englisch.pdf?__blob=publicationFile; 2020\/2021 [accessed 14 January 2022]."},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0225","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/21645515.2017.1367463","article-title":"Strategies in recommending influenza vaccination in Europe and US","volume":"14","author":"Rizzo","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.012_b0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1037\/hea0001045","article-title":"Decreasing vaccine hesitancy with extended health knowledge: Evidence from a longitudinal randomized controlled trial","volume":"40","author":"Eitze","year":"2021","journal-title":"Health Psychol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.012_b0235","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00103-012-1595-z","article-title":"Angst essen Impfbereitschaft auf? Der Einfluss kognitiver und affektiver Faktoren auf die Risikowahrnehmung im Ausbruchsgeschehen","volume":"56","author":"Betsch","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.012_b0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10865-018-9985-9","article-title":"The willingness to vaccinate increases when vaccination protects others who have low responsibility for not being vaccinated","volume":"42","author":"B\u00f6hm","year":"2019","journal-title":"J Behav Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.012_b0245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00103-019-02900-6","article-title":"Impfverhalten psychologisch erkl\u00e4ren, messen und ver\u00e4ndern","volume":"62","author":"Betsch","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.vaccine.2022.04.012_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102698","article-title":"Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis","volume":"48","author":"Nguyen","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"26","key":"10.1016\/j.vaccine.2022.04.012_b0255","doi-asserted-by":"crossref","first-page":"14890","DOI":"10.1073\/pnas.1919666117","article-title":"Vaccination as a social contract","volume":"117","author":"Korn","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.vaccine.2022.04.012_b0260","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.vaccine.2020.04.052","article-title":"Barriers and drivers to adult vaccination among family physicians - Insights for tailoring the immunization program in Germany","volume":"38","author":"Neufeind","year":"2020","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2025.126741","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T06:05:07Z","timestamp":1712383507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004285"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}